Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry.-论文-万方医学网

作者： Marita Knudsen,Pope ^[1] ; Dan,Atar ^[2] ; Arne,Svilaas ^[1] ; Torstein,Hole ^[3] ; Jørn Dalsgaard,Nielsen ^[4] ; Ulrik,Hintze ^[5] ; Milita,Crisby ^[6] ; Pekka,Raatikainen ^[7] ; K E Juhani,Airaksinen ^[8] ; Saverio,Virdone ^[9] ; Karen,Pieper ^[10] ; Gloria,Kayani ^[11] ; Jean-Yves,Le Heuzey ^[12] ; Jan,Steffel ^[13] ; Janina,Stepinska ^[13] ; Jean-Pierre,Bassand ^[13] ; A John,Camm ^[14] ; GARFIELD-AF Investigators ^[15]

作者单位： Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[1] Hamar Hospital, Innlandet Hospital Trust, Hamar, Norway. ^[2] Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. ^[3] Nymoen Medical Centre, Kongsberg, Norway. ^[4] Lipid Clinic, Oslo University Hospital, Oslo, Norway. ^[5] Clinic of Medicine and Rehabilitation, More and Romsdal Hospital Trust, Alesund, Norway. ^[6] Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Trondheim, Norway. ^[7] Department of Cardiology, Copenhagen University Hospital, Copenhagen University, Copenhagen, Denmark. ^[8] Department of Cardiology, Hospital of South West Jutland, Esbjerg, University of Southern Denmark, Denmark. ^[9] Department of Neurobiology, Care Science and Society, Karolinska University Hospital, Stockholm, Sweden. ^[10] Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Tampere, Finland. ^[11] Heart Centre, Turku University Hospital and University of Turku, Turku, Finland. ^[12] Thrombosis Research Institute, London, UK. ^[13] Georges Pompidou Hospital, René Descartes University, Paris, France. ^[14] Division of Electrophysiology and Pacing, Department of Cardiology, University Heart Center Zurich, Zurich, Switzerland. ^[15] Institute of Cardiology, Intensive Cardiac Therapy Clinic, Warsaw, Poland. ^[16] University of Besançon, Besancon, France. ^[17] Cardiology Clinical Academic Group Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK. ^[18]

主题词老年人(Aged);老年人, 80以上(Aged, 80 and over);抗凝药(Anticoagulants);心房颤动(Atrial Fibrillation);死亡原因(Cause of Death);药物处方(Drug Prescriptions);药物疗法, 联合(Drug Therapy, Combination);栓塞(Embolism);欧洲(Europe);女(雌)性(Female);纤维蛋白溶解药(Fibrinolytic Agents);人类(Humans);男(雄)性(Male);中年人(Middle Aged);血小板聚集抑制剂(Platelet Aggregation Inhibitors);前瞻性研究(Prospective Studies);登记(Registries);危险因素(Risk Factors);卒中(Stroke);治疗结果(Treatment Outcome)

DOI 10.1080/07853890.2021.1893897

PMID 33818226

发布时间 2023-11-02

检索历史清除

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry.

Annals of medicine

相似文献

Annals of medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry.

Annals of medicine

相似文献

Annals of medicine

相关期刊

检索历史清除